Risk score · Heart & circulation
Lipoprotein(a) Polygenic Score
Lipoprotein(a) is a cholesterol-carrying particle whose level is set largely by genetics and barely changes with lifestyle. High levels raise the risk of heart disease.
A risk score adds up many common variants, each with a small effect, into an estimate of genetic predisposition. It is not a diagnosis.
A polygenic score for Lipoprotein A
Genetic variants
- 43
Method
- Genome-wide significant variants
Built from studies of
- European 100%
Evaluated in
- European 73%, African 13%, East Asian 7%, South Asian 7%
Published
Trinder M et al. (2020). Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease. JAMA Cardiol.
References
- Burgess S, Ference BA, Staley JR, Freitag DF, Mason AM, Nielsen SF, 2018. Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis. JAMA Cardiol
Other heart & circulation risk scores
- Abdominal Aortic Aneurysm
- Atrial Fibrillation
- Blood Pressure
- Coronary Artery Disease
- Heart Failure
- LDL Cholesterol
- Stroke
- Venous Thromboembolism
One test. A lifetime of answers.
One kit, sent to your home. Your entire genome sequenced at the clinical standard used for diagnostic decisions. Physician-ready reports delivered to your Genome Manager in 6–8 weeks — permanent and updated as science advances.
Free shipping · Results in 6–8 weeks
Premium adds $99 per kit for the first year.
